| Composition | Gliclazide 80mg Metformin Hydrochloride 500mg |
|---|---|
| Dosage | TABLET |
| Packing Size | 20×10 |
| Packing | Blister |
At Avecia Healthcare, we believe that professionalism forms the foundation of trust. Our expert team is committed to providing healthcare solutions that meet global standards.
Every product we deliver is a result of thorough research, precision manufacturing, and rigorous quality checks—ensuring consistency in performance and reliability.
With a patient-first approach and a strong ethical foundation, we aim to make a lasting difference in lives by offering care that is both dependable and professionally crafted.
Glicafine M 80/500 is a fixed-dose combination anti-diabetic medicine that contains Gliclazide 80 mg and Metformin Hydrochloride 500 mg. It is prescribed for the effective management of Type 2 Diabetes Mellitus in patients whose blood sugar levels are not adequately controlled by diet, exercise, or monotherapy.
How It Works:
Gliclazide (80 mg): A sulfonylurea that stimulates insulin release from the pancreas, helping to lower blood glucose levels.
Metformin Hydrochloride (500 mg): A biguanide that decreases hepatic glucose production, enhances insulin sensitivity, and improves glucose uptake by muscles and tissues.
Together, these two agents provide synergistic action for better blood sugar control and reduced risk of long-term complications.
Key Benefits:
Dual action for effective glycemic control.
Improves insulin secretion and sensitivity.
Helps prevent complications like cardiovascular disease, neuropathy, nephropathy, and retinopathy.
Suitable for patients not controlled with a single anti-diabetic agent.
Indications:
Type 2 Diabetes Mellitus (when diet, lifestyle modifications, and monotherapy are inadequate).
Dosage & Administration:
To be taken as directed by the physician. Dosage may vary depending on the patient’s health condition and glucose levels.
Storage:
Store in a cool, dry place away from direct sunlight.
Keep out of reach of children.
Note:
Use only under medical supervision.
Not recommended for Type 1 Diabetes Mellitus or diabetic ketoacidosis.
